From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more

Back

Antiretroviral (ARV) Guidelines

First published:

2005

Last published:

April 2025

Overview

Explore the Australian Commentary to the US DHHS Guidelines for the use of Antiretroviral (ARV) Agents in HIV-1 Infected Adults and Adolescents and the Australian Commentary on the US DHHS Guidelines for the use of Antiretroviral Agents in Pediatric HIV infection. 

This comprehensive resource provides valuable insights and guidance for healthcare professionals involved in HIV management in Australia. Stay informed and enhance your HIV management practices with this essential commentary.